Table 2—

Mean ± SD skin autofluorescence at baseline and mean differences between groups

A: t0 absent/tfu absentB: t0 absent/tfu presentC: t0 present/tfu presentB vs. AC vs. AC vs. B
Microvascular complication
Retinopathy2.69 ± 0.732.88 ± 0.742.91 ± 0.720.200.220.02
    n64761169(−0.04 to 0.43)(0.07–0.37)(−0.24 to 0.29)
    P0.140.0021.00
Neuropathy2.67 ± 0.722.93 ± 0.752.88 ± 0.750.260.21−0.05
    n59666215(0.03–0.49)(0.07–0.35)(−0.29 to 0.20)
    P0.0190.0011.00
(Micro)albuminuria2.62 ± 0.682.91 ± 0.672.97 ± 0.830.280.340.06
    n57087207(0.09–0.48)(0.20–0.48)(−0.16 to 0.28)
    P0.002<0.0011.00
Any2.52 ± 0.692.86 ± 0.662.88 ± 0.750.340.360.01
    n322109441(0.15–0.53)(0.23–0.48)(−0.17 to 0.20)
    P<0.001<0.0011.00
  • Data are means ± SD of skin autofluorescence in AUs within the group or mean differences between groups (95% CI) (ANOVA with Bonferroni correction). t0, baseline; tfu, follow-up.